Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05967884
Title PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Ottawa Hospital Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
The Ottawa Hospital Research Institute and Cancer Center Ottawa Ontario K1Y 4E9 Canada Details
Ontario Institute for Cancer Research Toronto Ontario M5G 0A3 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field